Biology subjects

Faulon, J.-L.

Publications and source records attributed to Faulon, J.-L..

At least 19 recordsLinked to original sources

bioRxiv2026

Engineering growth-coupled metabolic biosensors for disease prognosis and diagnosis using full growth trajectories

Although metabolomics has shown considerable promise for biomarker discovery, and the development of diagnostic and prognostic applications, its translation into routine clinical practice remains limited by analytical complexity, cost, throughput, and standardization challenges. These limitations underscore the need for complementary tools, particularly in resource-limited settings. In this study, we developed a workflow for the engineering and characterization of growth-coupled metabolic sensors capable of disease detection (healthy vs. infected) and outcome prediction (mild vs. severe), which we illustrated using COVID-19 as a proof-of-concept application. We first generated a biomarker-guided library of 34 candidate sensors leveraging both auxotrophic phenotypes and less stringent metabolic dependencies. We then screened the library against patient plasma pools, identifying 19 sensor candidates with diagnostic and/or prognostic potential, including 14 with prognostic potential. Lastly, a selected subset of candidates was further evaluated on a patient cohort using two newly developed analytical frameworks designed to extract additional information from bacterial growth curves. The best-performing sensors achieved a balanced accuracy of 0.88{+/-} 0.06 for prognostic prediction (outer-test AUC = 0.89, 5-fold cross-validation, n = 37) and 1.00 for diagnostic classification (outer-test AUC = 1.00, 5-fold cross-validation, n = 56). Collectively, these findings establish a proof of concept for translating disease-associated plasmatic metabolic signatures into low-cost, growth-coupled biosensors with diagnostic and prognostic capabilities.

synthetic biology↗

bioRxiv2026

End-to-end mapping of membrane transport from chemical structure to microorganisms

Membrane transport is a fundamental biological process with profound implications for pharmacology, biotechnology, and microbiology. While computational approaches have largely adopted a protein-centric perspective to annotate transportomes, inferring transport function directly from the intrinsic properties of substrates remains a major challenge. Addressing transport at the compound level enables the systematic evaluation of whether molecules undergo active transport and by which mechanisms, independent of prior transporter annotation. Here, we introduce ChemProFlow, a comprehensive computational framework that redefines transport analysis from a substrate-centric perspective. By integrating geometric deep learning with orthology-based genomic mapping, ChemProFlow predicts molecular transportability, assigns transport mechanisms according to the Transporter Classification Database, and identifies the microorganisms encoding the corresponding transport systems. We show that this integrated pipeline enables scalable, end-to-end mapping of substrate-transporter-organism relationships, with broad applications in pharmacology for anticipating drug transport, in biotechnology for guiding strain engineering, and in microbiology for dissecting substrate utilization across diverse taxa. By capturing the chemical derminants of transportabiliy, ChemProFlow generalizes to previously unseen substrates and provides a high-throughput framework for systematic exploration of molecular transport across diverse biological contexts.

bioinformatics↗

bioRxiv2026

dAMN: a genome scale neural-mechanistic hybrid model to predict bacterial growth dynamics

SummaryThis study presents dAMN, a hybrid neural-mechanistic model that integrates neural networks with genome-scale dynamic flux balance analysis (dFBA) to predict bacterial growth curves across diverse nutrient environments. dAMN uses neural networks to infer dynamic behavior from initial metabolite concentrations, while mechanistic constraints ensure stoichiometric and thermodynamic consistency based on genome scale metabolic models. dAMN is trained on E. coli and P. putida experimental growth data from media containing various combinations of sugars, amino acids, and nucleobases, and evaluated on two test sets: one for forecasting over time and another for predicting growth dynamics on unseen media. dAMN achieved high predictive power (R2 [≥] 0.9), successfully reproducing growth and substrate depletion dynamics including acetate overflow and glucose-acetate consumption shift for E. coli. An interesting innovation of dAMN is the treatment of the lag phase, enabling realistic adaptation dynamics absent from standard dFBA models. dAMN stands out for its ability to generalize across combinatorial nutrient inputs and produce full growth-curve predictions from minimal input data. Availability and implementationThe dAMN software, along with the associated models and data, is available at https://github.com/brsynth/dAMN-main-release and via DOI 10.5281/zenodo.17908125

systems biology↗

bioRxiv2025

Cell-free genome-wide transcriptomics through machine learning optimization

1Despite advances in transcriptomics, understanding of genome regulation remains limited by the complex interactions within living cells. To address this, we performed cell-free transcriptomics by developing a platform using an active learning workflow to explore over 1,000,000 buffer conditions. This enabled us to identify a buffer that increased mRNA yield by 20-fold, enabling cell-free transcriptomics. By employing increasingly complex conditions, our approach untangles the regulatory layers controlling genome expression.

synthetic biology↗

bioRxiv2024

Operate a Cell-Free Biofoundry using Large Language Models

In this paper, we present a novel approach to optimizing cell-free protein synthesis (CFPS) systems using artificial intelligence (AI), specifically leveraging ChatGPT-4 for code generation and active learning (AL). This study aims to automate and enhance the process of producing antimicrobial proteins, namely colicin M and colicin E1, in CFPS systems. We developed an automated workflow that employs an iterative Design-Build-Test-Learn (DBTL) cycle, integrating a newly implemented AL method with cluster margin (CM) selection to efficiently explore experimental conditions. The workflow components, including modules for sampling, plate design, instruction generation, and data analysis, were coded using ChatGPT-4 without further human modification. By employing this automated approach, significant improvements in protein yields were achieved, with a 9-fold increase for colicin M and a 3-fold increase for colicin E1 compared to standard buffer compositions. The use of LLMs in conjunction with AL demonstrated the potential of AI-driven methodologies to accelerate the optimization of complex biological processes and reduce manual intervention. The study also discusses limitations such as variability in CFPS and suggests future improvements in automation, reproducibility, and integration of diverse liquid handling systems to further enhance the scalability and efficiency of cell-free biofoundries.

synthetic biology↗

bioRxiv2024

Reservoir Computing with Bacteria

We introduce a systems-level approach to sensing and computing in which Escherichia coli acts as a living reservoir computer, performing complex information processing through its native growth responses without requiring genetic modification or specialized instrumentation. We validate this framework by accurately classifying early-stage COVID-19 plasma samples (mild vs. severe) using only bacterial growth data, highlighting a diagnostic potential without infrastructure-dependent methods. By controlling nutrient media compositions, we also demonstrate that E. coli growth encodes nonlinear transformations that outperform linear regression, support vector machines, and multilayer perceptrons across diverse regression and classification tasks. Using simulations across genome-scale metabolic models from multiple bacterial species, we establish a strong link between phenotypic diversity and computational capacity, showing that learning capacities scale with the diversity of metabolic phenotypes. These findings position biological reservoir computing as a robust, scalable, and low-cost platform for intelligent biosensing, diagnostics, and hybrid bio-digital computation, while providing new mechanistic insights into the computational capabilities of living systems.

synthetic biology↗

bioRxiv2022

PeroxiHUB: a modular cell-free biosensing platform using H2O2 as signal integrator

Cell-free systems have great potential for delivering robust, cheap, and field-deployable biosensors. Many cell-free biosensors rely on transcription factors responding to small molecules, but their discovery and implementation still remain challenging. Here we report the engineering of PeroxiHUB, an optimized H2O2-centered sensing platform supporting cell-free detection of different metabolites. H2O2 is a central metabolite and a by-product of numerous enzymatic reactions. PeroxiHUB uses enzymatic transducers to convert metabolites of interest into H2O2, enabling rapid reprogramming of sensor specificity using alternative transducers. We first screen several transcription factors and optimize OxyR for the transcriptional response to H2O2 in cell-free, highlighting the need for pre-incubation steps to obtain suitable signal-to-noise ratios. We then demonstrate modular detection of metabolites of clinical interest - lactate, sarcosine, and choline - using different transducers mined via a custom retro-synthesis workflow publicly available on the SynBioCAD Galaxy portal. We find that expressing the transducer during the pre-incubation step is crucial for optimal sensor operation. Finally, we show that different reporters can be connected to PeroxiHUB, providing high adaptability for various applications. Given the wide range of enzymatic reactions producing H2O2, the PeroxiHUB platform will support cell-free detection of a large number of metabolites in a modular and scalable fashion.

synthetic biology↗

bioRxiv2022

Galaxy-SynBioCAD: Automated Pipeline for Synthetic Biology Design and Engineering

We introduce the Galaxy-SynBioCAD portal, the first toolshed for synthetic biology, metabolic engineering, and industrial biotechnology. The tools and workflows currently shared on the portal enables one to build libraries of strains producing desired chemical targets covering an end-to-end metabolic pathway design and engineering process from the selection of strains and targets, the design of DNA parts to be assembled, to the generation of scripts driving liquid handlers for plasmid assembly and strain transformations. Standard formats like SBML and SBOL are used throughout to enforce the compatibility of the tools. In a study carried out at four different sites, we illustrate the link between pathway design and engineering with the building of a library of E. coli lycopene-producing strains. We also benchmarked our workflows on literature and expert validated pathways. Overall, we find an 83% success rate in retrieving the validated pathways among the top 10 pathways generated by the workflows.

synthetic biology↗

bioRxiv2022

Artificial Metabolic Networks: enabling neural computation with metabolic networks

Constraint-based metabolic models have been used for decades to predict the phenotype of microorganisms in different environments. However, quantitative predictions are limited unless labor-intensive measurements of media uptake fluxes are performed. We show how hybrid neural-mechanistic models can serve as an architecture for machine learning providing a way to improve phenotype predictions. We illustrate our hybrid models with growth rate predictions of Escherichia coli and Pseudomonas putida grown in different media and with phenotype predictions of gene knocked-out Escherichia coli mutants. Our neural-mechanistic models systematically outperform constraint-based models and require training set sizes orders of magnitude smaller than classical machine learning methods. Our hybrid approach opens a doorway to enhancing constraint-based modeling: instead of constraining mechanistic models with additional experimental measurements, our hybrid models grasp the power of machine learning while fulfilling mechanistic constrains, thus saving time and resources in typical systems biology or biological engineering projects.

systems biology↗

bioRxiv2021

A versatile active learning workflow for optimization of genetic and metabolic networks

The study, engineering and application of biological networks require practical and efficient approaches. Current optimization efforts of these systems are often limited by wet lab labor and cost, as well as the lack of convenient, easily adoptable computational tools. Aimed at democratization and standardization, we describe METIS, a modular and versatile active machine learning workflow with a simple online interface for the optimization of biological target functions with minimal experimental datasets. We demonstrate our workflow for various applications, from simple to complex gene circuits and metabolic networks, including several cell-free transcription and translation systems, a LacI-based multi-level controller and a 27-variable synthetic CO2-fixation cycle (CETCH cycle). Using METIS, we could improve above systems between one and two orders of magnitude compared to their original setup with minimal experimental efforts. For the CETCH cycle, we explored the combinatorial space of [~]1025 conditions with only 1,000 experiments to yield the most efficient CO2-fixation cascade described to date. Beyond optimization, our workflow also quantifies the relative importance of individual factors to the performance of a system. This allows to identify so far unknown interactions and bottlenecks in complex systems, which paves the way for their hypothesis-driven improvement, which we demonstrate for the LacI multi-level controller that we were able to improve by 34-fold after having identified resource competition as limiting factor. Overall, our workflow opens the way for convenient optimization and prototyping of genetic and metabolic networks with customizable adjustments according to user experience, experimental setup, and laboratory facilities.

synthetic biology↗

bioRxiv2021

Differentially optimized cell-free buffer enables robust expression from unprotected linear DNA in exonuclease-deficient extracts

The use of linear DNA templates in cell-free systems promises to accelerate the prototyping and engineering of synthetic gene circuits. A key challenge is that linear templates are rapidly degraded by exonucleases present in cell extracts. Current approaches tackle the problem by adding exonuclease inhibitors and DNA-binding proteins to protect the linear DNA, requiring additional time- and resource-intensive steps. Here, we delete the recBCD exonuclease gene cluster from the Escherichia coli BL21 genome. We show that the resulting cell-free systems, with buffers optimized specifically for linear DNA, enable near-plasmid levels of expression from {sigma}70 promoters in linear DNA templates without employing additional protection strategies. When using linear or plasmid DNA templates at the buffer calibration step, the optimal potassium glutamate concentrations obtained when using linear DNA were consistently lower than those obtained when using plasmid DNA for the same extract. We demonstrate the robustness of the exonuclease deficient extracts across seven different batches and a wide range of experimental conditions across two different laboratories. Finally, we illustrate the use of the {Delta}recBCD extracts for two applications: toehold switch characterization and enzyme screening. Our work provides a simple, efficient, and cost-effective solution for using linear DNA templates in cell-free systems and highlights the importance of specifically tailoring buffer composition for the final experimental setup. Our data also suggest that similar exonuclease deletion strategies can be applied to other species suitable for cell-free synthetic biology.

synthetic biology↗

bioRxiv2020

Galaxy-SynBioCAD: Synthetic Biology Design Automation tools in Galaxy workflows

Many computer-aided design tools are available for synthetic biology and metabolic engineering. Yet, these tools can be difficult to apprehend, sometimes requiring a level of expertise that limits their use by a wider community. Furthermore, some of the tools, although complementary, rely on different input and output formats and cannot communicate with one another. Scientific workflows address these shortcomings while offering a novel design strategy. Among the workflow systems available, Galaxy is a web-based platform for performing findable and accessible data analyses for all scientists regardless of their informatics expertise, along with interoperable and reproducible computations regardless of the particular platform that is being used. Here, we introduce the Galaxy-SynBioCADa portal, the first Galaxy toolshed for synthetic biology and metabolic engineering. It allows one to easily create workflows or use those already developed by the community. The portal is a growing community effort where developers can add new tools and users can evaluate the tools performing design for their specific projects. The tools and workflows currently shared on the Galaxy-SynBioCAD portal cover an end-to-end metabolic pathway design process from the selection of strain and target to the calculation of DNA parts to be assembled to build libraries of strains to be engineered to produce the target. Standard formats are used throughout to enforce the compatibility of the tools. These include SBML for strain and pathway and SBOL for genetic layouts. The portal has been benchmarked on 81 literature pathways, overall, we find we have a 65% (and 88%) success rate in retrieving the literature pathways among the top 10 (50) pathways predicted and generated by the workflows.

bioengineering↗

bioRxiv2019

Similarity-guided Monte Carlo Tree Search for bio-retrosynthesis

Metabolic engineering aims to produce chemicals of interest from living organisms, to advance towards greener chemistry. Despite efforts, the research and development process is still long and costly and efficient computational design tools are required to explore the chemical biosynthetic space. Here, we propose to explore the bio-retrosynthesis space using an Artificial Intelligence based approach relying on the Monte Carlo Tree Search reinforcement learning method, guided by chemical similarity. We implement this method in RetroPath RL, an open-source and modular command line tool. We validate it on a golden dataset of 20 manually curated experimental pathways as well as on a larger dataset of 152 successful metabolic engineering projects. Moreover, we provide a novel feature, that suggests potential media supplements to complement the enzymatic synthesis plan.

bioinformatics↗

bioRxiv2019

Large scale active-learning-guided exploration to maximize cell-free production

Lysate-based cell-free systems have become a major platform to study gene expression but batch-to-batch variation makes protein production difficult to predict. Here we describe an active learning approach to explore a combinatorial space of ~4,000,000 cell-free compositions, maximizing protein production and identifying critical parameters involved in cell-free productivity. We also provide a one-step-method to achieve high quality predictions for protein production using minimal experimental effort regardless of the lysate quality.

synthetic biology↗

bioRxiv2019

Metabolic Perceptrons for Neural Computing in Biological Systems

AbstractSynthetic biological circuits are promising tools for developing sophisticated systems for medical, industrial, and environmental applications. So far, circuit implementations commonly rely on gene expression regulation for information processing using digital logic. Here, we present a new approach for biological computation through metabolic circuits designed by computer-aided tools, implemented in both whole-cell and cell-free systems. We first combine metabolic transducers to build an analog adder, a device that sums up the concentrations of multiple input metabolites. Next, we build a weighted adder where the contributions of the different metabolites to the sum can be adjusted. Using a computational model trained on experimental data, we finally implement two four-input \"perceptrons\" for desired binary classification of metabolite combinations by applying model-predicted weights to the metabolic perceptron. The perceptron-mediated neural computing introduced here lays the groundwork for more advanced metabolic circuits for rapid and scalable multiplex sensing.

synthetic biology↗

bioRxiv2018

Plug-and-Play Metabolic Transducers Expand the Chemical Detection Space of Cell-Free Biosensors

Cell-free transcription-translation systems have great potential for biosensing, yet the range of detectable chemicals is limited. Here we provide a framework to expand the range of molecules detectable by cell-free biosensors by combining synthetic metabolic cascades with transcription factor-based networks. These hybrid cell-free biosensors are highly-sensitive and have a fast response and high-dynamic range. This work provides a foundation to engineer modular cell-free biosensors tailored for many applications.

synthetic biology↗

bioRxiv2017

Selenzyme: Enzyme selection tool for pathway design

Synthetic biology applies the principles of engineering to biology in order to create biological functionalities not seen before in nature. One of the most exciting applications of synthetic biology is the design of new organisms with the ability to produce valuable chemicals including pharmaceuticals and biomaterials in a greener; sustainable fashion. Selecting the right enzymes to catalyze each reaction step in order to produce a desired target compound is, however, not trivial. Here, we present Selenzyme, a free online enzyme selection tool for metabolic pathway design. The user is guided through several decision steps in order to shortlist the best candidates for a given pathway step. The tool graphically presents key information about enzymes based on existing databases and tools such as: similarity of sequences and of catalyzed reactions; phylogenetic distance between source organism and intended host species; multiple alignment highlighting conserved regions, predicted catalytic site, and active regions; and relevant properties such as predicted solubility and transmembrane regions. Selenzyme provides bespoke sequence selection for automated workflows in biofoundries. The tool is integrated as part of the pathway design stage into the design-build-test-learn SYNBIOCHEM pipeline. The Selenzyme web server is available at http://selenzyme.synbiochem.co.uk.

bioinformatics↗

bioRxiv2017

PartsGenie: an integrated tool for optimising and sharing synthetic biology parts

Synthetic biology is typified by developing novel genetic constructs from the assembly of reusable synthetic DNA parts, which contain one or more features such as promoters, ribosome binding sites, coding sequences and terminators. While repositories of such parts exist to promote their reuse, there is still a need to design novel parts from scratch.\n\nPartsGenie, freely available at http://parts.synbiochem.co.uk, is introduced to facilitate the computational design of such synthetic biology parts. PartsGenie has been designed to bridge the gap between optimisation tools for the design of novel parts, the representation of such parts in community-developed data standards such as Synthetic Biology Open Language (SBOL), and their sharing in journal-recommended data repositories.\n\nConsisting of a drag-and-drop web interface, a number of DNA optimisation algorithms, and an interface to the well-used data repository JBEI ICE, PartsGenie facilitates the design, optimisation and dissemination of reusable synthetic biology parts through a single, integrated application. PartsGenie can therefore be used as a single, stand-alone tool, or integrated into larger synthetic biology pipelines that are being developed in the SYNBIOCHEM centre and elsewhere.

synthetic biology↗